Literature DB >> 3900340

Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats.

L J Kaufman, R R Vollmer.   

Abstract

The influence of endogenous angiotensin II on the hemodynamic responses to electrical stimulation of the sympathetic outflow was assessed in pithed male normotensive Wistar rats fitted with aortic flow probes for continuous measurement of cardiac output (CO). The frequency-related increments (0.25-4.0 Hz) in blood pressure (BP) and total peripheral resistance (TPR) were significantly attenuated by treating animals with the angiotensin converting enzyme inhibitor captopril (5 mg/kg i.v.) or the angiotensin II receptor antagonist saralasin (10 micrograms/kg/min i.v.). However, the increments in CO and heart rate during neural stimulation were unaffected by blockade of the renin-angiotensin system. After captopril treatment, infusion of angiotensin II (40 ng/kg/min i.v.) to replace the loss of endogenous angiotensin II restored stimulation-induced TPR and BP responses toward precaptopril levels; CO and heart rate responses to stimulation were not altered. The hemodynamic responses to exogenous norepinephrine were affected by inhibition of the renin-angiotensin system with captopril and saralasin in a manner analogous to the neurally mediated responses. The results obtained with nerve stimulation and norepinephrine indicate that endogenous angiotensin II selectively interacted with sympathetic neural control of vascular resistance, whereas cardiac responsiveness to noradrenergic neurons was not altered. Moreover, in the absence of nerve stimulation, the antagonism of the renin-angiotensin system lowered base-line BP by reducing CO without measurably affecting TPR. Infusion of angiotensin II reversed these effects and restored BP toward precaptopril levels by increasing CO without measurably affecting TPR.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900340

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Chronic treatment of the spontaneously hypertensive rat with captopril attenuates responses to noradrenaline in vivo but not in vitro.

Authors:  J Atkinson; M Sonnay; M Sautel; A K Fouda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

2.  Probable involvement of vascular angiotensin II formation in the beta 2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat.

Authors:  E Schlicker; K Erkens; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

Review 3.  Control of cardiomyocyte gene expression as drug target.

Authors:  H Rupp; M Benkel; B Maisch
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

4.  Blockade by nifedipine of responses to intravenous bolus injection or infusion of alpha 1- and alpha 2-adrenoceptor agonists in the pithed rat.

Authors:  J C McGrath; J W O'Brien
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

5.  Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.

Authors:  C Richer; V Domergue; M P Vincent; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.

Authors:  T L Grant; J C McGrath
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

7.  Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats.

Authors:  M R MacLean; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

8.  Effect of artificial respiratory volume on the cardiovascular responses to an alpha 1- and an alpha 2-adrenoceptor agonist in the air-ventilated pithed rat.

Authors:  M R MacLean; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

9.  Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

Authors:  B Clemson; L Gaul; S S Gubin; D M Campsey; J McConville; J Nussberger; R Zelis
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.